Molecular and Cellular Basis for the Analgesic Properties of N-Arachidonyl amino acids

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic pain affects 20% of the population of Australia, but current treatments for chronic pain are often problematic. A recently described class of compounds, the arachidonyl amino acids, show particular promise as analgesic agents, but at present there is very little understanding of how these compounds mediate their analgesic effects. In this project we will apply a variety of molecular, cellular and behavioural approaches to understand how the arachidonyl amino acids provide pain relief.

Funded Activity Details

Start Date: 01-01-2006

End Date: 01-01-2008

Funding Scheme: NHMRC Project Grants

Funding Amount: $509,017.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacology and Pharmaceutical Sciences

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

N-arachidonyl amino acids | electrophysiology | inflammation | pain | spinal cord | transporters, receptors and ion channels